R A Rode
Overview
Explore the profile of R A Rode including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
241
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Caterson I, Finer N, Coutinho W, Van Gaal L, Maggioni A, Torp-Pedersen C, et al.
Diabetes Obes Metab
. 2011 Dec;
14(6):523-30.
PMID: 22192338
Aim: The Sibutramine Cardiovascular OUTcomes trial showed that sibutramine produced greater mean weight loss than placebo but increased cardiovascular morbidity but not mortality. The relationship between 12-month weight loss and...
2.
Ferguson N, Donnelly C, Hooper J, Ghani A, Fraser C, Bartley L, et al.
J R Soc Interface
. 2006 Jul;
2(4):349-63.
PMID: 16849193
We analyse data on patient adherence to prescribed regimens and surrogate markers of clinical outcome for 168 human immunodeficiency virus infected patients treated with antiretroviral therapy. Data on patient adherence...
3.
Donnelly C, Bartley L, Ghani A, Le Fevre A, Kwong G, Cowling B, et al.
HIV Med
. 2005 May;
6(3):170-8.
PMID: 15876283
Objectives: To test and characterize the dependence of viral load on gender in different countries and racial groups as a function of CD4 T-cell count. Methods: Plasma viral load data...
4.
Kempf D, ISAACSON J, King M, Brun S, Xu Y, Real K, et al.
J Virol
. 2001 Jul;
75(16):7462-9.
PMID: 11462018
The association of genotypic changes in human immunodeficiency virus (HIV) protease with reduced in vitro susceptibility to the new protease inhibitor lopinavir (previously ABT-378) was explored using a panel of...
5.
Kempf D, Rode R, Xu Y, Sun E, Valdes J, Japour A, et al.
AIDS
. 1998 Apr;
12(5):F9-14.
PMID: 9543434
Objective: To determine markers that are associated with the durability of virologic response to therapy with HIV protease inhibitors in HIV-infected individuals. Design: This study encompassed two retrospective analyses of...
6.
Chetkowski R, Rode R, Burruel V, Nass T
Fertil Steril
. 1991 Dec;
56(6):1095-103.
PMID: 1743328
Objective: To examine the effect of pituitary suppression and the women's age on embryo viability and uterine receptivity. Design: Retrospective analysis of 394 embryo transfers (ET) after in vitro fertilization...
7.
Hardy D, SWANSON R, Rode R, Marsh K, Shipkowitz N, Clement J
Antimicrob Agents Chemother
. 1990 Jul;
34(7):1407-13.
PMID: 2143642
MICs of clarithromycin and its major human metabolite, 14-hydroxy-clarithromycin, for Haemophilus influenzae in combination were reduced two- to fourfold compared with the MICs of each compound alone. Serum reduced the...
8.
Fernandes P, Ramer N, Rode R, Freiberg L
Eur J Clin Microbiol Infect Dis
. 1988 Feb;
7(1):73-6.
PMID: 2967754
A-56268 is a new macrolide which is generally two-fold more potent than erythromycin. A new bioassay is described in which plasma samples are extracted with acetonitrile prior to bioassay. The...
9.
Hanson C, Bailer R, Gade E, Rode R, Fernandes P
J Clin Microbiol
. 1987 Jun;
25(6):1079-82.
PMID: 2954995
A-56268 is a 6-O-methyl derivative of erythromycin A which has a spectrum of activity similar to that of erythromycin and is 1 log2 dilution more potent than erythromycin against most...